KHC vs LBRX · P/E 12, rev $12.31B vs $803.4M cap
Kraft Heinz Co (KHC) versus LB Pharmaceuticals Inc Common Stock (LBRX) — a side-by-side from cached financials, not a winner call.
Kraft Heinz Co (KHC) is a packaged foods company listed on US.
LB Pharmaceuticals Inc Common Stock (LBRX) is a biotechnology company listed on NASDAQ.
Latest reported KHC revenue for 2026-06-27 was $12.31B. Net income was -$4.66B. KHC currently screens at market cap $31.55B and trailing P/E 12.2.
LBRX does not have a complete income-statement cache yet.
KHC currently screens at market cap $31.55B and trailing P/E 12.2. LBRX currently screens at market cap $803.4M.
Not investment advice. Open the KHC and LBRX stock pages for the full models.
Not investment advice.